UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

  FORM 12b-25 SEC FILE NUMBER
    001-38448
     
  NOTIFICATION OF LATE FILING CUSIP NUMBER
    984163 105

 

(Check one) : o Form 10-K              o Form 20-F              o Form 11-K              x Form 10-Q              o Form 10-D              o Form N-SAR
  o Form N-CSR
   
  For Period Ended: March 31, 2018
   
  o Transition Report on Form 10-K
  o Transition Report on Form 20-F
  o Transition Report on Form 11-K
  o Transition Report on Form 10-Q
  o Transition Report on Form N-SAR
   
  For the Transition Period Ended: ______________________________

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

PART I - REGISTRANT INFORMATION

 

Xspand Products Lab, Inc.

Full Name of Registrant

 

 

Former Name if Applicable

 

4030 Skyron Drive, Suite F

Address of Principal Executive Office (Street and Number)

 

Doylestown, Pennsylvania 18902 

City, State and Zip Code

 

PART II - RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

  (a)The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
   
x (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
   
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 

 

 

PART III - NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

Xspand Products Lab, Inc. (the “Registrant”) is unable to file, without unreasonable effort or expense, its quarterly report on Form 10-Q for the quarter ended March 31, 2018 because the Registrant was not able to complete timely its financial statements without unreasonable effort or expense. The Registrant currently anticipates that its Form 10-Q for the quarter ended March 31, 2018 will be filed as soon as practicable, and no later than five days calendar days following its prescribed due date.

 

PART IV - OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Christopher B. Ferguson   (610)   829-1039
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).          Yes  x    No  ¨   

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?          Yes ¨    No  x

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

 

 

  Xspand Products Lab, Inc.  

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date May 15, 2018   By   /s/ Christopher B. Ferguson
        Christopher B. Ferguson
        Chief Executive Officer

 

 

 

Xspand Products Lab, Inc. (delisted) (NASDAQ:XSPL)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Xspand Products Lab, Inc. (delisted) Charts.
Xspand Products Lab, Inc. (delisted) (NASDAQ:XSPL)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Xspand Products Lab, Inc. (delisted) Charts.